{"id":"https://openalex.org/W52551801","doi":null,"title":"Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies.","display_name":"Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W52551801","mag":"52551801","pmid":"https://pubmed.ncbi.nlm.nih.gov/24518521"},"language":"en","primary_location":{"id":"pmid:24518521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24518521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051483089","display_name":"Noa Biran","orcid":"https://orcid.org/0000-0003-0693-4202","observed_orcids":["https://orcid.org/0000-0003-0693-4202","https://orcid.org/0000-0002-9001-0645"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noa Biran","raw_affiliation_strings":["Hematology and medical oncology fellow at the Icahn School of Medicine at Mount Sinai in New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and medical oncology fellow at the Icahn School of Medicine at Mount Sinai in New York, New York","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028046297","display_name":"Sundar Jagannath","orcid":"https://orcid.org/0000-0003-2934-6518","observed_orcids":["https://orcid.org/0000-0003-2934-6518"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sundar Jagannath","raw_affiliation_strings":["Director of the Multiple Myeloma Program and a professor of hematology and medical oncology at the Icahn School of Medicine at Mount Sinai in New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of the Multiple Myeloma Program and a professor of hematology and medical oncology at the Icahn School of Medicine at Mount Sinai in New York, New York","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006108161","display_name":"Ajai Chari","orcid":"https://orcid.org/0000-0002-0405-7480","observed_orcids":["https://orcid.org/0000-0002-0405-7480"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajai Chari","raw_affiliation_strings":["Director of clinical research in the Multiple Myeloma Program and an assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of clinical research in the Multiple Myeloma Program and an assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York, New York","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":null,"apc_paid":null,"fwci":0.6389,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.70263721,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":"9","first_page":"578","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.9879999756813049},{"id":"https://openalex.org/keywords/genetic-risk-factors","display_name":"genetic risk factors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.878000020980835},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.902999997138977},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/chromosome-13-deletion","display_name":"chromosome 13 deletion","score":0.8190000057220459},{"id":"https://openalex.org/keywords/chromosome-17p-deletion","display_name":"chromosome 17p deletion","score":0.9660000205039978},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.8930000066757202},{"id":"https://openalex.org/keywords/novel-therapies","display_name":"new drugs","score":0.6370000243186951},{"id":"https://openalex.org/keywords/disease-reclassification","display_name":"disease reclassification","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9234856367111206},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6873533725738525},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.6401225924491882},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.613743782043457},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5363683700561523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49820637702941895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4914928674697876},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.42689383029937744},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3453260064125061},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002872","descriptor_name":"Chromosome Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002882","descriptor_name":"Chromosomes, Human, Pair 13","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002886","descriptor_name":"Chromosomes, Human, Pair 17","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D025063","descriptor_name":"Chromosome Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058496","descriptor_name":"Smith-Magenis Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:24518521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24518521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},{"id":"mag:52551801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24518521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1595022239","https://openalex.org/W2002605588","https://openalex.org/W2011871138","https://openalex.org/W2012454018","https://openalex.org/W2014073139","https://openalex.org/W2026448323","https://openalex.org/W2029006246","https://openalex.org/W2039496823","https://openalex.org/W2051146376","https://openalex.org/W2055338149","https://openalex.org/W2057527782","https://openalex.org/W2066800926","https://openalex.org/W2068076832","https://openalex.org/W2072077329","https://openalex.org/W2075032656","https://openalex.org/W2081225837","https://openalex.org/W2087843841","https://openalex.org/W2088765731","https://openalex.org/W2096207943","https://openalex.org/W2108235071","https://openalex.org/W2120780398","https://openalex.org/W2123159083","https://openalex.org/W2124560610","https://openalex.org/W2125721471","https://openalex.org/W2126351771","https://openalex.org/W2128084036","https://openalex.org/W2128903704","https://openalex.org/W2142149038","https://openalex.org/W2151595053","https://openalex.org/W2316160054","https://openalex.org/W2567567773","https://openalex.org/W2980227790"],"related_works":["https://openalex.org/W2044186114","https://openalex.org/W2595388903","https://openalex.org/W2137128912","https://openalex.org/W2182756547","https://openalex.org/W92094363","https://openalex.org/W4394782733","https://openalex.org/W2896440840","https://openalex.org/W1984350956","https://openalex.org/W2021785646","https://openalex.org/W1978828632"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1],"(MM)":[2],"is":[3,99],"a":[4,8],"heterogeneous":[5],"disease,":[6],"and":[7,48,116],"variety":[9],"of":[10,16,29,50,62,113,128,134,141],"risk":[11,56],"factors":[12,57],"at":[13],"the":[14,26,35,67,84,132,139],"time":[15],"initial":[17],"diagnosis":[18],"can":[19],"be":[20,59],"used":[21],"to":[22,52,69,122],"stratify":[23],"patients.":[24],"In":[25],"first":[27],"part":[28,127],"this":[30,129],"2-part":[31],"series,":[32],"we":[33],"reviewed":[34],"currently":[36],"identified":[37],"prognostic":[38],"factors,":[39,45],"characterized":[40],"by":[41],"disease":[42],"burden,":[43],"host":[44],"tumor":[46],"biology,":[47],"depth":[49],"response":[51],"therapy.":[53],"However,":[54],"these":[55],"cannot":[58],"interpreted":[60],"independently":[61],"therapies.":[63],"Novel":[64],"therapies":[65,143],"have":[66],"potential":[68],"worsen":[70],"or":[71,81],"improve":[72],"outcomes":[73,103],"compared":[74],"with":[75,101,106],"conventional":[76],"therapy":[77],"in":[78,89,104,138],"high-risk":[79,85,107],"patients,":[80],"actually":[82],"overcome":[83,123],"status,":[86],"thereby":[87],"resulting":[88],"reclassification":[90],"as":[91,111],"standard":[92],"risk.":[93],"For":[94],"example,":[95],"thalidomide":[96],"(Thalomid,":[97],"Celgene)":[98],"associated":[100],"worse":[102],"patients":[105],"cytogenetic":[108],"abnormalities,":[109],"such":[110],"deletion":[112],"chromosomes":[114],"13":[115],"17p,":[117],"whereas":[118],"proteasome":[119],"inhibitors":[120],"appear":[121],"t(4;14).":[124],"The":[125],"second":[126],"series":[130],"reviews":[131],"significance":[133],"various":[135],"genetic":[136],"risks":[137],"era":[140],"novel":[142],"for":[144],"MM.":[145]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}